These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38109936)

  • 1. De novo design of high-affinity binders of bioactive helical peptides.
    Vázquez Torres S; Leung PJY; Venkatesh P; Lutz ID; Hink F; Huynh HH; Becker J; Yeh AH; Juergens D; Bennett NR; Hoofnagle AN; Huang E; MacCoss MJ; Expòsit M; Lee GR; Bera AK; Kang A; De La Cruz J; Levine PM; Li X; Lamb M; Gerben SR; Murray A; Heine P; Korkmaz EN; Nivala J; Stewart L; Watson JL; Rogers JM; Baker D
    Nature; 2024 Feb; 626(7998):435-442. PubMed ID: 38109936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo design of protein structure and function with RFdiffusion.
    Watson JL; Juergens D; Bennett NR; Trippe BL; Yim J; Eisenach HE; Ahern W; Borst AJ; Ragotte RJ; Milles LF; Wicky BIM; Hanikel N; Pellock SJ; Courbet A; Sheffler W; Wang J; Venkatesh P; Sappington I; Torres SV; Lauko A; De Bortoli V; Mathieu E; Ovchinnikov S; Barzilay R; Jaakkola TS; DiMaio F; Baek M; Baker D
    Nature; 2023 Aug; 620(7976):1089-1100. PubMed ID: 37433327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HelixGAN a deep-learning methodology for conditional de novo design of α-helix structures.
    Xie X; Valiente PA; Kim PM
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36651657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Diffusion Model for Stable, Affinity-Driven, Receptor-Aware Peptide Generation.
    R VS; Choudhuri S; Ghosh B
    J Chem Inf Model; 2024 Sep; 64(17):6912-6925. PubMed ID: 39193724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hotspot-centric de novo design of protein binders.
    Fleishman SJ; Corn JE; Strauch EM; Whitehead TA; Karanicolas J; Baker D
    J Mol Biol; 2011 Nov; 413(5):1047-62. PubMed ID: 21945116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusing protein binders to intrinsically disordered proteins.
    Liu C; Wu K; Choi H; Han H; Zhang X; Watson JL; Shijo S; Bera AK; Kang A; Brackenbrough E; Coventry B; Hick DR; Hoofnagle AN; Zhu P; Li X; Decarreau J; Gerben SR; Yang W; Wang X; Lamp M; Murray A; Bauer M; Baker D
    bioRxiv; 2024 Jul; ():. PubMed ID: 39071267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-Specific
    Wang F; Wang Y; Feng L; Zhang C; Lai L
    J Chem Inf Model; 2024 Sep; ():. PubMed ID: 39266056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design of ligand-binding proteins with high affinity and selectivity.
    Tinberg CE; Khare SD; Dou J; Doyle L; Nelson JW; Schena A; Jankowski W; Kalodimos CG; Johnsson K; Stoddard BL; Baker D
    Nature; 2013 Sep; 501(7466):212-216. PubMed ID: 24005320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrp) chimeric peptides.
    Schievano E; Mammi S; Silvestri L; Behar V; Rosenblatt M; Chorev M; Peggion E
    Biopolymers; 2000 Nov; 54(6):429-47. PubMed ID: 10951329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo design of buttressed loops for sculpting protein functions.
    Jiang H; Jude KM; Wu K; Fallas J; Ueda G; Brunette TJ; Hicks DR; Pyles H; Yang A; Carter L; Lamb M; Li X; Levine PM; Stewart L; Garcia KC; Baker D
    Nat Chem Biol; 2024 Aug; 20(8):974-980. PubMed ID: 38816644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational design and optimization of novel d-peptide TNFα inhibitors.
    Yang W; Zhang Q; Zhang C; Guo A; Wang Y; You H; Zhang X; Lai L
    FEBS Lett; 2019 Jun; 593(12):1292-1302. PubMed ID: 31102258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the affinity of selective bZIP-binding peptides through surface residue redesign.
    Kaplan JB; Reinke AW; Keating AE
    Protein Sci; 2014 Jul; 23(7):940-53. PubMed ID: 24729132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design of protein interactions with learned surface fingerprints.
    Gainza P; Wehrle S; Van Hall-Beauvais A; Marchand A; Scheck A; Harteveld Z; Buckley S; Ni D; Tan S; Sverrisson F; Goverde C; Turelli P; Raclot C; Teslenko A; Pacesa M; Rosset S; Georgeon S; Marsden J; Petruzzella A; Liu K; Xu Z; Chai Y; Han P; Gao GF; Oricchio E; Fierz B; Trono D; Stahlberg H; Bronstein M; Correia BE
    Nature; 2023 May; 617(7959):176-184. PubMed ID: 37100904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: implications for receptor-activating conformations of the hormones.
    Barbier JR; MacLean S; Morley P; Whitfield JF; Willick GE
    Biochemistry; 2000 Nov; 39(47):14522-30. PubMed ID: 11087406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening.
    Zhang H; Saravanan KM; Wei Y; Jiao Y; Yang Y; Pan Y; Wu X; Zhang JZH
    J Chem Inf Model; 2023 Feb; 63(3):835-845. PubMed ID: 36724090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane binding and structure of de novo designed alpha-helical cationic coiled-coil-forming peptides.
    Vagt T; Zschörnig O; Huster D; Koksch B
    Chemphyschem; 2006 Jun; 7(6):1361-71. PubMed ID: 16680794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate de novo design of hyperstable constrained peptides.
    Bhardwaj G; Mulligan VK; Bahl CD; Gilmore JM; Harvey PJ; Cheneval O; Buchko GW; Pulavarti SV; Kaas Q; Eletsky A; Huang PS; Johnsen WA; Greisen PJ; Rocklin GJ; Song Y; Linsky TW; Watkins A; Rettie SA; Xu X; Carter LP; Bonneau R; Olson JM; Coutsias E; Correnti CE; Szyperski T; Craik DJ; Baker D
    Nature; 2016 Oct; 538(7625):329-335. PubMed ID: 27626386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific targeting of intrinsically disordered protein regions.
    Wu K; Jiang H; Hicks DR; Liu C; Muratspahic E; Ramelot TA; Liu Y; McNally K; Gaur A; Coventry B; Chen W; Bera AK; Kang A; Gerben S; Lamb MY; Murray A; Li X; Kennedy MA; Yang W; Schober G; Brierley SM; Gelb MH; Montelione GT; Derivery E; Baker D
    bioRxiv; 2024 Sep; ():. PubMed ID: 39071356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.